Reneo Pharmaceuticals And 2 Other Stocks Under $5 Executives Are Buying

Reneo Pharmaceuticals和其他2只股票在5美元以下，執行官正在購買

Benzinga · 09/17 21:01

The Dow Jones index closed higher by over 200 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

道瓊斯指數週一收漲超過200點。當內部人士購買或出售股票時，這表明他們對公司前景的信心或擔憂。對於對低價股感興趣的投資者和交易者來說，可以將此作爲他們整體投資或交易決策的一個因素。

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

以下是幾個近期關於低價股的值得關注的內部交易。了解更多，請查看Benzinga內幕交易平台。

Exicure

exicure

The Trade: Exicure, Inc. (NASDAQ:XCUR) 10% owner DGP Co., Ltd. bought a total of 237,223 shares at an average price of $3.00. To acquire these shares, it cost around $711,669.
What's Happening: On Sept. 13, Exicure entered into debt-for-equity exchange agreements..
What Exicure Does: Exicure Inc is a biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss.

交易：exicure公司（納斯達克：XCUR）的10％所有者DGP Co.，Ltd.以平均價格爲3.00美元購買了237,223股股票。爲了獲得這些股票，花費約爲711,669美元。
正在發生的事情：9月13日，exicure公司與債務對等出售協議達成一致。
exicure是一家生物技術公司，專注於開發針對神經系統紫質酸治療靶向已驗證靶標的療法，用於神經系統失調和脫髮。

Amylyx Pharmaceuticals

Amylyx藥品

The Trade: Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) CFO James M Frates acquired a total of 40,000 shares at an average price of $2.53. To acquire these shares, it cost around $101,368.
What's Happening: On Aug. 8, Amylyx Pharma posted an in-line quarterly loss.
What Amylyx Pharmaceuticals Does: Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases.

交易：Amylyx藥品公司（NASDAQ：AMLX）首席財務官James m Frates以平均價格2.53美元購買了總計40,000股股票。爲了獲得這些股票，花費約爲101,368美元。
正在發生的事情：8月8日，Amylyx Pharma發佈了一份符合預期的季度虧損報告。
Amylyx Pharmaceuticals的業務：Amylyx Pharmaceuticals Inc是一家臨床階段的製藥公司，致力於開發治療肌萎縮性側索硬化症和其他神經退行性疾病的新型療法。